首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: A large prospective trial
【24h】

Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: A large prospective trial

机译:阴道(Crinone 8%)凝胶与油中肌肉内孕酮在体外受精中用于黄体期支持的一项大型前瞻性试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To compare the efficacy of intravaginal and IMP for luteal phase support in IVF cycles. Design: Prospective trial. Setting: Tertiary care private practice. Patient(s): Women 25-44 years old with infertility necessitating treatment with IVF. From April 1, 2008-April 1, 2009, 511 consecutive patients were enrolled; 474 completed participation, and 37 were excluded for no autologous ET (freeze all, donor recipients, failed fertilization/cleavage). There were no demographic differences between the two treatment groups. Intervention(s): Luteal phase support using either Crinone or P in oil starting 2 days following oocyte retrieval. Main Outcome Measure(s): Pregnancy and delivery rates stratified by patient age. Result(s): Overall, patients who received vaginal P had higher pregnancy (70.9% vs. 64.2%) and delivery (51.7% vs. 45.4%) rates than did patients who received IMP. Patients <35 who received vaginal P had significantly higher delivery rates (65.7% vs. 51.1%) than did patients who received IMP. There were no differences, regardless of age, in the rates of biochemical pregnancy, miscarriage, or ectopics. Conclusion(s): In younger patients undergoing IVF, support of the luteal phase with Crinone produces significantly higher pregnancy rates than does IMP. Crinone and IMP appear to be equally efficacious in the older patient.
机译:目的:比较阴道内和IMP对IVF周期中黄体期支持的疗效。设计:前瞻性试验。地点:三级私人护理诊所。患者:年龄在25-44岁之间的不育女性,需要进行IVF治疗。从2008年4月1日至2009年4月1日,共纳入511例患者。 474位完整的参与者,其中37位因无自体ET而被排除在外(冻结所有捐赠者,受精/切割失败)。两个治疗组之间没有人口统计学差异。干预:在卵母细胞取出后2天开始,在油中使用Crinone或P进行黄体期支持。主要观察指标:妊娠和分娩率,按患者年龄分层。结果:总体而言,接受阴道P的患者比接受IMP的患者妊娠率更高(70.9%对64.2%)和分娩率(51.7%对45.4%)。 <35岁接受阴道P的患者的分娩率显着高于接受IMP的患者(65.7%对51.1%)。不论年龄大小,生化妊娠,流产或异位的发生率均无差异。结论:在进行IVF的年轻患者中,使用Crinone对黄体期的支持产生的妊娠率显着高于IMP。 Crinone和IMP在老年患者中似乎同样有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号